An optimised dosing regimen versus a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in neonates and infants aged less than 90 days (NeoVanc): study protocol for a randomised controlled trial



Hill, Louise F, Turner, Mark A ORCID: 0000-0002-5299-8656, Lutsar, Irja, Heath, Paul T, Hardy, Pollyanna, Linsell, Louise, Jacqz-Aigrain, Evelyne, Roilides, Emmanuel, Sharland, Mike and Consortium, NeoVanc
(2020) An optimised dosing regimen versus a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in neonates and infants aged less than 90 days (NeoVanc): study protocol for a randomised controlled trial. TRIALS, 21 (1).

[img] Text
An optimised dosing regimen versus a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gra.pdf - OA Published Version

Download (1MB) | Preview
Item Type: Article
Uncontrolled Keywords: Neonate, Late-onset sepsis, Vancomycin, coagulase negative staphylococci, Randomised controlled trial, Non-inferiority, Loading dose
Depositing User: Symplectic Admin
Date Deposited: 13 May 2020 09:47
Last Modified: 26 Aug 2021 12:10
DOI: 10.1186/s13063-020-4184-8
Open Access URL: https://doi.org/10.1186/s13063-020-4184-8
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3087072